Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,097
Scalp Cooling in MBC
for
Metastatic Breast Cancer, Chemotherapy-induced Alopecia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04986579
Phase2, Recruiting
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Location: Boston MA, New Hyde Park NY, Houston TX, La Jolla CA
Sponsor: Chronic Lymphocytic Leukemia Research Consortium
Sex: All
Age: 0+
Code: NCT00628238
Phase2, Recruiting
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: Boston MA, Houston TX, Duarte CA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT03113643
Phase1, Recruiting
Avelumab and M1774 in ARID1A-mutated Endometrial Cancer
for
Endometrial Cancer, ARID1A Gene Mutation,
Location: Boston MA
Sponsor: Panagiotis Konstantinopoulos, MD, PhD
Sex: Female
Age: 18+
Code: NCT06518564
Phase2, Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Boston MA, Westbury NY, New York NY, Washington D.C. DC,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
for
Non Small Cell Lung Cancer, Triple Negative Breast Cancer,
Location: Boston MA, Buffalo NY, Fort Wayne IN, Athens GA,
Sponsor: Compass Therapeutics
Sex: All
Age: 18+
Code: NCT06150664
Phase1, Recruiting
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
for
Castration Resistant Metastatic Prostate Cancer
Location: Boston MA, Baltimore MD, Minneapolis MN, Omaha NE,
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: Male
Age: 18 - 70+
Code: NCT04363164
Phase2, Recruiting
Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma
for
Merkel Cell Carcinoma
Location: Boston MA, New York NY, Fairfax VA, Toronto,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT03787602
Phase1, Phase2, Recruiting
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT03310879
Phase2, Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Boston MA, New York NY, Baltimore MD, Cleveland OH,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06034002
Phase1, Recruiting
CONFIRM: Magnetic Resonance Guided Radiation Therapy
for
Gastric Cancer, Invasive Breast Cancer, in Situ Breast Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18+
Code: NCT04368702
Recruiting
Developing Fast Pediatric Imaging
for
Pediatric Low-grade Gliomas
Location: Boston MA
Sponsor: Boston Children's Hospital
Sex: All
Age: 0+
Code: NCT03761121
Recruiting
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
for
EGFRI Induced Acneiform Lesions
Location: Boston MA, New York NY, Neptune NJ, Philadelphia PA,
Sponsor: Lutris Pharma Ltd.
Sex: All
Age: 18+
Code: NCT04759664
Phase2, Recruiting
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
for
Acute Myeloid Leukemia,
Location: Boston MA, Baltimore MD, Chapel Hill NC, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05886049
Phase1, Recruiting
BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome
for
Acute Myeloid Leukemia,
Location: Boston MA
Sponsor: Eric Stephen Winer, MD
Sex: All
Age: 18+
Code: NCT05703542
Phase1, Recruiting
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
for
Solid Tumor, Adult, Mesothelioma, NSCLC
Location: Boston MA, New York NY, Arlington VA, Chicago IL,
Sponsor: Vivace Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT04665206
Phase1, Phase2, Recruiting
Psilocybin in Cancer Pain Study
for
Opioid-Related Disorders, Pain Management,
Location: Boston MA
Sponsor: Yvan Beaussant, MD, MSci
Sex: All
Age: 18+
Code: NCT06001749
Phase2, Recruiting
Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
for
Relapsed Classic Hodgkin Lymphoma
Location: Boston MA, Hackensack NJ, Chicago IL, Nashville TN,